Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)TipRanks · 27 Apr 2026
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9Market news · 27 Apr 2026
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7Market news · 25 Feb 2026
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7Market news · 21 Feb 2026
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $10Market news · 19 Feb 2026
BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5Market news · 19 Feb 2026
Truist Financial Maintains Bausch Health(BHC.US) With Hold RatingMarket news · 19 Feb 2026
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8Market news · 7 Jan 2026
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8Market news · 24 Jan 2026
Raymond James Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8Market news · 5 Aug 2025
Discussion
No comments yet — be the first to weigh in on BHC.
No comments yet — be the first to weigh in on BHC.